March 13 – 16, 2023 | London

Celebrating 13 years and 13 approved ADC’s, World ADC is back and better than ever this March.

With over 211 antibody-drug conjugate clinical trials breaking ground throughout 2022, a plethora of positive clinical results, expansion of antibody-drug conjugates to novel indications, an exponential increase in investments and collaborations, and the industry-changing recent approval of ImmunoGen’s ELAHERE, there has been no more important time to invest in progressing your ADCs and unite the community.

Uniting 400+ peers of the ADC community, including Beacon’s ADC Insight Lead, Jake Morris, with an exclusive presentation exploring ‘The Current State of the ADC Landscape‘, the highly anticipated 13^th World ADC London is Europe’s only discussion and networking forum dedicated to addressing and overcoming the challenges in end-to-end ADC development.